Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medios AG (DE:ILM1)
XETRA:ILM1
Holding DE:ILM1?
Track your performance easily
ILM1 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€11.24 - €18.50
Previous Close€12.08
Volume8.47K
Average Volume (3M)41.36K
Market Cap
€308.11M
Enterprise Value€246.53M
Total Cash (Recent Filing)€79.21M
Total Debt (Recent Filing)€17.63M
Price to Earnings (P/E)22.9
Beta0.72
Next Earnings
Mar 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.53
Shares OutstandingN/A
10 Day Avg. Volume87,037
30 Day Avg. Volume41,359
Standard Deviation0.12
R-Squared0.05
Alpha-0.00309
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.27
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€25.80Price Target Upside114.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Medios AG News
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
0.25% Mutual Funds
― Other Institutional Investors
99.23% Public Companies and
Individual Investors
ILM1 FAQ
What was Medios AG’s price range in the past 12 months?
Medios AG lowest stock price was €11.24 and its highest was €18.50 in the past 12 months.
What is Medios AG’s market cap?
Currently, no data Available
When is Medios AG’s upcoming earnings report date?
Medios AG’s upcoming earnings report date is Mar 26, 2025 which is in 89 days.
How were Medios AG’s earnings last quarter?
Medios AG released its earnings results on Nov 12, 2024. The company reported €0.158 earnings per share for the quarter, beating the consensus estimate of N/A by €0.158.
Is Medios AG overvalued?
According to Wall Street analysts Medios AG’s price is currently Undervalued.
Does Medios AG pay dividends?
Medios AG does not currently pay dividends.
What is Medios AG’s EPS estimate?
Medios AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medios AG have?
Medios AG has 25,505,724 shares outstanding.
What happened to Medios AG’s price movement after its last earnings report?
Medios AG reported an EPS of €0.158 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.141%.
Which hedge fund is a major shareholder of Medios AG?
Currently, no hedge funds are holding shares in DE:ILM1
---
Medios AG Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-74.90%
12-Months-Change
Fundamentals
Return on Equity
2.64%
Trailing 12-Months
Asset Growth
53.94%
Trailing 12-Months
Company Description
Medios AG
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. It operates through the following segments: Provision of Medicinal Products, Patient-specific Therapies, and Services. The Provision of Medicinal Products segment focuses on specialty pharmaceuticals means it trades almost exclusively in expensive medicinal products for chronic and/or rare diseases. The Patient-specific Therapies segment include infusions constituted and produced on the basis of individual symptoms and individual parameters such as body weight and body surface. The Services segment consists of all other Group activities, including Medios Group holding activities. The company was founded in 1980 and is headquartered in Berlin, Germany.
---
ILM1 Company Deck
---
ILM1 Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with strong financial performance and strategic advancements, despite some challenges in specific segments and increased costs related to acquisitions.Read More>---
ILM1 Stock 12 Month Forecast
Average Price Target
€25.80
▲(114.78% Upside)
Technical Analysis
BioLife Solutions
―
Healthequity
―
Fate Therapeutics
―
Medios AG
―
REPRO-MED Systems
―
Best Analysts Covering ILM1
1 Year
1 Year Success Rate
1/13 ratings generated profit
1 Year Average Return
-20.43%
reiterated a buy rating 14 days ago
Copying Michael Heider's trades and holding each position for 1 Year would result in 7.69% of your transactions generating a profit, with an average return of -20.43% per trade.
---